FDA's Draft Template Eases Medical Device Question Submissions
Published Date: 5/29/2025
Notice
Summary
The FDA just shared a draft guide to help medical device makers send their Pre-Submission requests electronically using a new template. This change aims to make submissions easier and faster to review, but it’s not official yet, so no need to rush. If you work with medical devices, keep an eye out for when this guide becomes final—it could save you time and hassle!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Draft electronic Pre-Sub template
The FDA released a draft guidance introducing an electronic submission template for certain Q-Submissions, specifically Pre-Submissions (Pre-subs) to the Center for Devices and Radiological Health (CDRH) and the Center for Biologics Evaluation and Research (CBER). The template is intended to help industry improve submission consistency and enhance efficiency in the review process.
Draft guidance — not yet binding
The FDA states the guidance is draft, not final, and not for implementation at this time. If you submit Pre-Submissions to CDRH or CBER, you do not need to change your processes yet or comply with this draft guidance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
Previous / Next Documents
Previous: 2025-09613 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June 2025 to review and decide on cancer research grant applications. These meetings protect private info and trade secrets, so the public can’t attend. Researchers applying for grants should note these dates, as the decisions could impact funding and future cancer studies.
Next: 2025-09616 — Agency Information Collection Activities; Revision of a Currently Approved Collection: Biographic Information (for Deferred Action)
USCIS is updating the form that collects personal info for people asking for Deferred Action, which helps some folks stay in the U.S. without fear of deportation. This update might change how long it takes to fill out the form but won’t add extra costs. If you’re applying or helping someone apply, keep an eye out and share your thoughts before the deadline!